These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 27564662

  • 1. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S, Welte T.
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [Abstract] [Full Text] [Related]

  • 2. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F.
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [Abstract] [Full Text] [Related]

  • 3. Alpha-1 Antitrypsin and Lung Cell Apoptosis.
    Serban KA, Petrache I.
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S146-9. PubMed ID: 27115949
    [Abstract] [Full Text] [Related]

  • 4. Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.
    Santangelo S, Scarlata S, Poeta ML, Bialas AJ, Paone G, Incalzi RA.
    Curr Med Chem; 2017 Apr; 24(1):65-90. PubMed ID: 27855621
    [Abstract] [Full Text] [Related]

  • 5. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
    Geraghty P, Rogan MP, Greene CM, Brantly ML, O'Neill SJ, Taggart CC, McElvaney NG.
    Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
    [Abstract] [Full Text] [Related]

  • 6. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD, Crystal RG.
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [Abstract] [Full Text] [Related]

  • 7. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M.
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [Abstract] [Full Text] [Related]

  • 8. Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.
    Cosio MG, Bazzan E, Rigobello C, Tinè M, Turato G, Baraldo S, Saetta M.
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S305-10. PubMed ID: 27564665
    [Abstract] [Full Text] [Related]

  • 9. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC, Crystal RG.
    Am J Med; 1988 Jun 24; 84(6A):52-62. PubMed ID: 3289387
    [Abstract] [Full Text] [Related]

  • 10. Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD.
    Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J.
    Exp Lung Res; 2012 Aug 24; 38(6):302-6. PubMed ID: 22686467
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema.
    Ni K, Serban KA, Batra C, Petrache I.
    Ann Am Thorac Soc; 2016 Aug 24; 13 Suppl 4(Suppl 4):S311-6. PubMed ID: 27564666
    [Abstract] [Full Text] [Related]

  • 12. Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives.
    McNulty MJ, Silberstein DZ, Kuhn BT, Padgett HS, Nandi S, McDonald KA, Cross CE.
    Free Radic Biol Med; 2021 Feb 01; 163():10-30. PubMed ID: 33279618
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT, Vimalanathan S.
    Int J Tuberc Lung Dis; 2008 Apr 01; 12(4):361-7. PubMed ID: 18371259
    [Abstract] [Full Text] [Related]

  • 14. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK, Mosley JD, Rao DC, Palmer LJ, Province MA, Elston RC, Weiss ST, Campbell EJ.
    Hum Hered; 2001 Apr 01; 52(4):223-32. PubMed ID: 11713419
    [Abstract] [Full Text] [Related]

  • 15. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.
    Churg A, Wang RD, Xie C, Wright JL.
    Am J Respir Crit Care Med; 2003 Jul 15; 168(2):199-207. PubMed ID: 12689849
    [Abstract] [Full Text] [Related]

  • 16. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI, Mumford RA, Treonze KM, Finke PE, Davies P, Si Q, Humes JL, Dirksen A, Piitulainen E, Ahmad A, Stockley RA.
    Thorax; 2011 Aug 15; 66(8):686-91. PubMed ID: 21617168
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF, Miravitlles M.
    Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837
    [Abstract] [Full Text] [Related]

  • 18. High-level production of wild-type and oxidation-resistant recombinant alpha-1-antitrypsin in glycoengineered CHO cells.
    Koyuturk I, Kedia S, Robotham A, Star A, Brochu D, Sauvageau J, Kelly J, Gilbert M, Durocher Y.
    Biotechnol Bioeng; 2022 Sep 30; 119(9):2331-2344. PubMed ID: 35508753
    [Abstract] [Full Text] [Related]

  • 19. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM, Louie SG.
    Expert Opin Pharmacother; 2007 Oct 30; 8(15):2609-14. PubMed ID: 17931094
    [Abstract] [Full Text] [Related]

  • 20. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
    Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, Lauzon JL, Maltais F, O'Donnell DE, Goodridge D, Strange C, Cave AJ, Curren K, Muthuri S, Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group.
    Can Respir J; 2012 Oct 30; 19(2):109-16. PubMed ID: 22536580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.